Effectiveness of a mHealth Intervention for the Treatment of Depression in People With Diabetes or Hypertension in Peru

Summary

Background: Depression is a common comorbidity of physical chronic diseases such as diabetes and/or hypertension and constitutes an important public health problem. It correlates negatively with the patients' quality of life and self-care, as well as compliance with medical treatment. In low- and middle-income countries depression often goes unrecognized and untreated, and there are limited human resources to treat depression and other mental problems.

Aim: The present study aims to test a 6-week low-intensity psychological intervention (CONEMO - CONtrol EMOcional) delivered by a smartphone application to people with depressive symptoms and co-morbid diabetes and/or hypertension recruited in primary health care centers and public hospitals in Lima, Peru.

Conditions

• Depression
• Diabetes
• Hypertension

Interventions

BEHAVIORAL

CONEMO

Participants will be offered a behavioral activation-based intervention delivered by an application for smartphones (CONEMO) oriented to encourage them to be more active and to incorporate more activities in participants' everyday life. Nurses will train participants to use CONEMO, make phone calls when participants are non-adherent, and provide technical support when necessary. Nurses will be supervised by clinical psychologists.

Sponsors & Collaborators

• University of Sao Paulo General Hospital

  collaborator OTHER

• National Institute of Mental Health (NIMH)

  collaborator NIH

• Northwestern University

  collaborator OTHER

• Universidad Peruana Cayetano Heredia

  lead OTHER

Principal Investigators

• Paulo R Menezes, MD, PhD · University of Sao Paulo General Hospital

• Ricardo B Araya, MD, PhD · London School of Hygiene and Tropical Medicine

• Jaime Miranda, MD, PhD · Universidad Peruana Cayetano Heredia

• Lisa Colpe, PhD · National Institute of Mental Health (NIMH)

• Francisco Diez-Canseco, MSc, MPH · Universidad Peruana Cayetano Heredia

• Lena R Brandt, MSc · Universidad Peruana Cayetano Heredia

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

21 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2017-01-24

Primary Completion

2018-03-31

Completion

2018-12-19

Countries

• Peru

Study Locations